 CORAL GABLES, Fla., July 26, 2021 GLOBE NEWSWIRE -- Catalyst Pharmaceuticals, Inc. Catalyst Nasdaq: CPRX, a commercial-stage, patient-centric biopharmaceutical company focused on in-licensing, developing and commercializing novel high-quality medicines for patients living with rare diseases, today announced that it will release second quarter 2021 financial results after market close on Monday, August 9, 2021. Further, Catalyst management will host an investment-community conference call at 8:30 a.m. ET on Tuesday, August 10, 2021 to discuss the financial results and to provide a corporate update. 